194 related articles for article (PubMed ID: 27853930)
1. A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions.
Elad S; Ranna V; Ariyawardana A; Correa ME; Tilly V; Nair RG; Rouleau T; Logan RM; Pinto A; Charette V; Saunders DP; Jensen SB;
Support Care Cancer; 2017 Feb; 25(2):687-700. PubMed ID: 27853930
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea.
Elad S; Zadik Y; Hewson I; Hovan A; Correa ME; Logan R; Elting LS; Spijkervet FK; Brennan MT;
Support Care Cancer; 2010 Aug; 18(8):993-1006. PubMed ID: 20544224
[TBL] [Abstract][Full Text] [Related]
3. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
4. Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature.
Brennan MT; Elting LS; Spijkervet FK
Support Care Cancer; 2010 Aug; 18(8):979-84. PubMed ID: 20306090
[TBL] [Abstract][Full Text] [Related]
5. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Elad S; Cheng KKF; Lalla RV; Yarom N; Hong C; Logan RM; Bowen J; Gibson R; Saunders DP; Zadik Y; Ariyawardana A; Correa ME; Ranna V; Bossi P;
Cancer; 2020 Oct; 126(19):4423-4431. PubMed ID: 32786044
[TBL] [Abstract][Full Text] [Related]
6. Management of oral lesions in HIV-positive patients.
Baccaglini L; Atkinson JC; Patton LL; Glick M; Ficarra G; Peterson DE
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S50.e1-23. PubMed ID: 17379155
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
Asbell PA
Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
[TBL] [Abstract][Full Text] [Related]
8. Nongenital herpes simplex virus.
Usatine RP; Tinitigan R
Am Fam Physician; 2010 Nov; 82(9):1075-82. PubMed ID: 21121552
[TBL] [Abstract][Full Text] [Related]
9. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Wagstaff AJ; Faulds D; Goa KL
Drugs; 1994 Jan; 47(1):153-205. PubMed ID: 7510619
[TBL] [Abstract][Full Text] [Related]
10. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
[TBL] [Abstract][Full Text] [Related]
12. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
13. [Battle with herpes for 37 years].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
[TBL] [Abstract][Full Text] [Related]
14. Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update.
Bowen JM; Elad S; Hutchins RD; Lalla RV;
Support Care Cancer; 2013 Jan; 21(1):303-8. PubMed ID: 22960942
[TBL] [Abstract][Full Text] [Related]
15. Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH; Korting HC
Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
[TBL] [Abstract][Full Text] [Related]
16. The role of basic oral care and good clinical practice principles in the management of oral mucositis.
McGuire DB; Correa ME; Johnson J; Wienandts P
Support Care Cancer; 2006 Jun; 14(6):541-7. PubMed ID: 16775649
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
18. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Valacyclovir to Prevent Outbreaks of Primary Herpes Gladiatorum at a 28-Day Wrestling Camp: A 10-Year Review.
Anderson BJ; McGuire DP; Reed M; Foster M; Ortiz D
Clin J Sport Med; 2016 Jul; 26(4):272-8. PubMed ID: 26540599
[TBL] [Abstract][Full Text] [Related]
20. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
